GlobeNewswire

Elastic Announces Recipients of 2018 Elastic Cause Awards

Dela

Honors Standout Projects from the Elastic Community that Advance the Greater Good

SAN FRANCISCO, Feb. 27, 2018 (GLOBE NEWSWIRE) -- (Elastic{ON} 2018) - Elastic, the company behind Elasticsearch and the Elastic Stack, today announced recipients of the second Elastic Cause Awards at the Elastic{ON} 2018 opening keynote address. Celebrating the passion, innovation and dedication of the Elastic community, the 2018 Elastic Cause Awards recognize four projects that push the boundaries of Elastic software to improve the world. This year's honorees are: DimagiLibraries Without Borders (Bibliothèques Sans Frontières)Refugee Datathon Munich, and Thorn : Digital Defenders of Children.

The Elastic Cause Awards are part of Elastic's expanding philanthropic mission, which will continue to grow to further benefit nonprofits using the Elastic Stack. Now in its second year, the Cause Awards included nominations from dozens of organizations working to advance the human condition, improve the environment or help a local, regional or global population in need. Judges included Elastic Founder and CEO Shay Banon, VP of Human Resources Leah Sutton and a panel of Elastic developer, product, and customer experts, who evaluated entries based on their impact, altruism, and reach. Each of the selected project teams received complimentary conference tickets and hotel stay for up to two project members and will be featured in various events at Elastic{ON} 2018.

"When we started Elastic, I knew our software products could be used to help developers solve critical use cases within their organizations, but I never anticipated the impact it would have on solving humanitarian, and environment issues around the globe," said Banon. "I'm inspired by the life-changing initiatives we've learned about through this year's Elastic Cause Awards, and humbled by the small part we play in making it possible."

Dimagi
Dimagi is helping to fight the tuberculosis (TB) epidemic in India-which accounts for 23 percent of TB cases worldwide-with an integrated mobile and web application that helps healthcare workers keep track of TB patients. Built on Dimagi's software platform, CommCare, the app leverages the Elastic Stack to follow beneficiaries from the time of their initial diagnosis and throughout the course of their care, providing actionable data throughout. The app currently aggregates real-time data to track 150,000 patients in select districts.

"Every three minutes in India, two people die of tuberculosis. It's an epidemic needing immediate attention and innovative solutions," said Farid Rener, senior engineer, Dimagi. "We believe that mobile solutions can transform the efficiency, quality and impact of service delivery programs. By combining our mobile data collection platform with the power of the Elastic Stack, we are improving the efficiency that workers can follow-up with patients, and giving government decision makers a more accurate and timely view of the efficacy of current programs."

Libraries Without Borders (Bibliothèques Sans Frontières)
Libraries Without Borders facilitates free, open access to information and education, equipping vulnerable communities around the world with the tools and skills to learn and to thrive. The organization is rolling out digital libraries (KoomBook) as well as portable, "pop up" digital media centers (Ideas Box) that provide educational and cultural resources to communities in need, including refugees and displaced persons in camps around the globe and underserved communities in developed countries. Log analysis and dashboards delivered through the Elastic Stack provide instantaneous insight into digital resource usage and users' browsing habits and interests, enabling the organization to more effectively assess impact and relevance, and improve the user experience.

"The Elastic Stack's capacity to process various raw logs while at the same time generating appealing visuals perfectly matches our needs," said Steven Walliman, Digital Projects Manager, Bibliothèques Sans Frontières. "In providing the IT team with a better view of performance and stability, and librarians with the ability to measure relevance of their choices, the Elastic Stack enhances the impact of our projects. We look forward to deepening the links between our two organizations as we make good on our vision to empower vulnerable populations and transform the lives of millions people around the world."

Refugee Datathon Munich
Amidst a massive wave of support for refugees in Munich, Refugee Datathon Munich was started in autumn 2015 to provide up-to-date and reliable numbers for pro-refugee activists across Europe. The organization's software extracts statistical data on asylum seekers from official websites, then relies on the Elastic Stack to visualize the data before publishing the information. The software helps activists stay on top of current trends in asylum (e.g. approval rates by countries of origin), while serving the general public by disproving erroneous statements and biased reports about refugees.

"When we saw activists struggling with Excel to explain the refugee situation, we realized there was a need to give them more explorative power with more up-to-date data and less work," said Suny Kim, Data Architect, Refugee Datathon Munich. "The Elastic Stack helps us unlock the wealth of data from Eurostat statistics and visualize the information in an interactive way. For us, this is what democracy is about: get informed, get involved. The global refugee situation is one of the great challenges of our time, and our project is part of the democratic process to meet this challenge in a decent and adequate way."

Thorn: Digital Defenders of Children 
Co-founded by Ashton Kutcher and Demi Moore, Thorn builds technology to defend children from sexual abuse. Every moment counts when it comes to finding and saving more kids.Thorn uses the Elastic Stack throughout its products to streamline features that help law enforcement search through millions of records and quickly find the small pieces of information to identify a child. In 2016 and 2017, Spotlight, which accelerates identification of child victims of sex trafficking, helped identify 5,791 child sex trafficking victims (eight per day.) Thorn's other product, Solis, has been used by law enforcement in 17 countries and has rescued 72 victims of child sexual abuse whose images were being distributed on the dark web.

"It's by partnering with leading technology companies like Elastic that we're able to build cutting-edge tools that find child sexual abuse victims faster, make online environments safer, and deter criminal behavior," said Julie Cordua, CEO of Thorn. "Working at the intersection of child sexual abuse and technology, we know technology is powerful, and we choose to use it for good -- to successfully fight child sex trafficking and other online trafficking."

Elastic Cause Award finalists include:

  • Action Network: helping progressive organizations target advocacy and outreach
  • CBC Radio: enabling the discovery of new and emerging music artists in all genres
  • Factr: facilitating global problem solving with collaborative intelligence streams
  • Mark43: reducing violent crime through better software
  • Internet of Things for Disaster Risk Reduction (IoT-DRR): reducing disaster risk through monitoring and analyzing smart rainwater tanks and river water levels
  • University of Bristol: facilitating the application of Mendelian randomization
  • US NAVY: protecting sailors and soldiers of the US Navy through cybersecurity
  • Virginia Polytechnic Institute and State University (Virginia Tech): monitoring watersheds for environmental and agricultural stakeholders
  • weblyzard Technology: creating an environmental web intelligence portal for the United Nations Environment Programme (UNEP) to identify opinion leaders and structure the public debate by topic and geographic location
  • Zebra Medical Vision: curating clinical and algorithmic datasets

Learn More

About Elastic
Elastic builds software to make data usable in real time and at scale for search, logging, security, and analytics use cases. Founded in 2012, the company develops the open source Elastic Stack (Elasticsearch, Kibana, Beats, and Logstash), X-Pack (commercial features), and Elastic Cloud (a hosted offering). To date, there have been more than 225 million cumulative downloads. Backed by Benchmark Capital, Index Ventures, and NEA with more than $100 million in funding, Elastic has a distributed workforce with more than 800 employees in 30 countries. Learn more at elastic.co.

Media Contacts
Michael Lindenberger
Reidy Communications for Elastic
Michael@reidycommunications.com
(415) 531-1449

EMEA
Rory MacDonald
Age of Peers Ltd for Elastic
rory@ageofpeers.com
+44 (0)7899 965232

 




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Elastic via Globenewswire

Om

GlobeNewswire



Följ GlobeNewswire

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från GlobeNewswire

Arcoma AB: Arcoma presenterar på Redeye Life Science Day den 21:a november16.11.2018 12:53Pressmeddelande

16 November Den 21 november presenterar Jesper Söderqvist, VD på Arcoma, den senaste utvecklingen i Arcoma på Haymarket by Scandic i Stockholm. Presentationen "Arcoma, ett tillväxtbolag i en växande marknad" hålls klockan 13:00 och kan följas i livesändning på redeye.se/live/lsday-2018. Presentationen kommer även i efterhand att finnas tillgänglig på www.redeye.se/live/ls-day-2018 samt på Bolagets sida i Redeye Universe (redeye.se/company/Arcoma) Om Arcoma Arcoma, med lång erfarenhet av branschen, är en ledande leverantör av integrerade digitala röntgensystem med hög kvalitet och avancerad teknik. Arcomas produkter erbjuder den senaste digitala bildtekniken kombinerat med tekniskt avancerade rörliga positioneringssystem, vilket tillsammans med ergonomisk skandinavisk design, erbjuder kunden kompletta, konfigurerbara och funktionella digitala röntgensystem. Bolagets produkter säljs via återförsäljare samt via OEM-kunder och det finns idag över 3 500 av Arcomas röntgensystem installerade

Iconovo: kundprojekt blir framflyttat tre till sex månader8.11.2018 15:45Pressmeddelande

Fortsatt arbete med ett av Iconovos pågående kundprojekt kommer att flyttas fram tre till sex månader. Projektet avser utveckling av produkt anpassad för kund som ska svara för produktion och marknadslansering. Det aktuella arbetet var planerat att ske under fjärde kvartalet men beräknas ske under nästa år, och detta påverkar Iconovos omsättning under 2018 negativt med cirka 2 miljoner kronor. Orsaken är att kunden har beslutat att genomföra en mindre klinisk studie för att verifiera produkten innan nästa steg tas vilken omfattar investeringar i betydande mångmiljonbelopp i produktionskapacitet, baserat på Iconovos utveckling. Studien görs för kundens egna räkning och är inte villkorad av tillsynsmyndigheter. "Detta påverkar vårt resultat på kort sikt, men det faktum att kunden har beslutat att göra en betydande investering i faktisk produktion betyder att vi med stor säkerhet kan se fram emot licensintäkter under en lång tidsrymd framöver i samband med att produkten lanseras på markna

Stillfront Group AB: Inbjudan till Stillfront Groups kvartalsrapport för tredje kvartalet 20187.11.2018 14:34Pressmeddelande

PRESSMEDDELANDE 7 november 2018 Inbjudan till Stillfront Groups kvartalsrapport för tredje kvartalet 2018 Stillfront Groups kvartalsrapport för det tredje kvartalet 2018 kommer att publiceras klockan 07.00 den 22 november 2018. En webbsänd telefonkonferens kommer att hållas klockan 10.00 samma dag där Jörgen Larsson, VD och Sten Wranne, CFO, kommenterar resultatet. Presentationen och rapporten kommer efter presentationen att finnas tillgänglig på www.stillfront.com Webbsändningen nås på adressen: https://tv.streamfabriken.com/stillfront-q3-2018 För att delta via telefon, vänligen ring: SE: +46 8 566 426 63 UK: +44 20 300 898 01 US: +1 8 557 532 235 FÖR YTTERLIGARE INFORMATION, VÄNLIGEN KONTAKTA: Sofia Wretman, IR Phone: +46 708 11 64 30 sofia@stillfront.com OM STILLFRONT Stillfront är en oberoende utvecklare, förläggare och distributör av digitala spel - med visionen att bli en ledande indie-spelutvecklare och förläggare. Stillfront är verksamt genom tio näst intill självständiga dotte

Stillfront Group AB: Invitation to Stillfront Group Q3 presentation7.11.2018 14:34Pressmeddelande

Invitation to Stillfront Group Q3 presentation Stillfront Group interim report for the third quarter 2018 will be published at 07.00 CET on 22 November 2018. A presentation of the report will be held the same day at 10.00 CET via telephone conference or audiocast where Jörgen Larsson, CEO and CFO Sten Wranne are to comment on the report. The presentation can be viewed live at https://tv.streamfabriken.com/stillfront-q3-2018 To participate via phone please call: SE: +46 8 566 426 63 UK: +44 20 300 898 01 US: +1 8 557 532 235 FOR FURTHER INFORMATION, PLEASE CONTACT: Sofia Wretman, IR Phone: +46 708 11 64 30 sofia@stillfront.com ABOUT STILLFRONT Stillfront is a group of independent creators, publishers and distributors of digital games - with a vision to become the leading group of indie game creators and publishers. Stillfront operates through ten near-autonomous subsidiaries: Bytro Labs in Germany, Coldwood Interactive in Sweden, Power Challenge in the UK and Sweden, Dorado Online Games

Modus Therapeutics announces FDA Acceptance of Sevuparin IND for the treatment of sickle cell disease7.11.2018 08:30Pressmeddelande

STOCKHOLM, November 7, 2018. Karolinska Development's portfolio company Modus Therapeutics announces today that the U.S Food & Drug Administration (FDA) has approved the company's Investigational New Drug (IND) application to initiate a Phase I clinical trial with subcutaneous sevuparin for the treatment of sickle cell disease (SCD) FDA has decided to accept Modus Therapeutics' IND application of sevuparin for the treatment of SCD. Sevuparin is an innovative, proprietary modified polysaccharide drug with anti-adhesive, anti-aggregate and anti-inflammatory effects due to its multimodal mechanism of action. It has the potential to restore blood flow and prevent further microvascular obstructions in children and adults with SCD. At present, sevuparin is being evaluated as an intravenous infusion in a Phase II study in SCD patients with ongoing painful crises (also called vaso occlusive crises, VOC). In order to broaden the clinical scope and utility of sevuparin in the treatment of SCD, t

Modus Therapeutics announces FDA Acceptance of Sevuparin IND for the treatment of sickle cell disease7.11.2018 08:30Pressmeddelande

STOCKHOLM, November 7, 2018. Karolinska Development's portfolio company Modus Therapeutics announces today that the U.S Food & Drug Administration (FDA) has approved the company's Investigational New Drug (IND) application to initiate a Phase I clinical trial with subcutaneous sevuparin for the treatment of sickle cell disease (SCD) FDA has decided to accept Modus Therapeutics' IND application of sevuparin for the treatment of SCD. Sevuparin is an innovative, proprietary modified polysaccharide drug with anti-adhesive, anti-aggregate and anti-inflammatory effects due to its multimodal mechanism of action. It has the potential to restore blood flow and prevent further microvascular obstructions in children and adults with SCD. At present, sevuparin is being evaluated as an intravenous infusion in a Phase II study in SCD patients with ongoing painful crises (also called vaso occlusive crises, VOC). In order to broaden the clinical scope and utility of sevuparin in the treatment of SCD, t

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum